SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XILLIX FDA APPROVED -- Ignore unavailable to you. Want to Upgrade?


To: Garry K. who wrote (320)10/26/1998 12:16:00 AM
From: burner  Read Replies (2) | Respond to of 572
 
Garry,
I agree with you and maybe the company does too! The program was called Investors OnLine and I watch it on Saturday mornings at 10:00 pacific time
The CEO, Leduc I think, was on but didn't really say too much in my opinion. At least they are aware that they need to get the message out. I hope does call the company. This stock seems unusually low right now..
Regards,
Dan



To: Garry K. who wrote (320)10/26/1998 11:20:00 AM
From: Robert Dydo  Read Replies (1) | Respond to of 572
 
Garry,
I don't know as much about technical issues of one's product or medicine. Someone who wants to investigate opportunities in this sector the valid point of good investment would be the title of this thread.
I mean how many Canadian companies are selling deeply under a $1 and have this status?
This is the market reaction to company which have a product detecting beginnings of lung cancers in the rate of 171% better that anything out there?
Who is not going to benefit from such a successful rate? Only those who are making the rest of the equipment available now, of course.
Unforunately young, weak financially company signs the distribution agreement with those who have so much to lose. There are agreements in place, future developments of products, I don't know if Xillix can
even promote its own product without Olympus approval, certainly they control the development of other ones.
Robert